Wave Life Sciences Ltd (NASDAQ: WVE) kicked off on Monday, down -3.81% from the previous trading day, before settling in for the closing price of $6.03. Over the past 52 weeks, WVE has traded in a range of $4.25-$16.74.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 607.85% over the past five years. While this was happening, its average annual earnings per share was recorded -36.01%. With a float of $122.54 million, this company’s outstanding shares have now reached $153.04 million.
Let’s look at the performance matrix of the company that is accounted for 288 employees. In terms of profitability, gross margin is 60.69%, operating margin of -101.94%, and the pretax margin is -89.57%.
Wave Life Sciences Ltd (WVE) Insider and Institutional Ownership
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Wave Life Sciences Ltd is 20.16%, while institutional ownership is 79.53%. The most recent insider transaction that took place on Mar 20 ’25, was worth 102,574. In this transaction Director of this company sold 10,500 shares at a rate of $9.77, taking the stock ownership to the 16,115 shares. Before that another transaction happened on Mar 20 ’25, when Company’s Director proposed sale 10,500 for $9.77, making the entire transaction worth $102,579.
Wave Life Sciences Ltd (WVE) Latest Financial update
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.24 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -36.01% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 6.34% during the next five years compared to 34.27% growth over the previous five years of trading.
Wave Life Sciences Ltd (NASDAQ: WVE) Trading Performance Indicators
Take a look at Wave Life Sciences Ltd’s (WVE) current performance indicators. Last quarter, stock had a quick ratio of 2.89. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 8.22.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.79, a number that is poised to hit -0.25 in the next quarter and is forecasted to reach -0.98 in one year’s time.
Technical Analysis of Wave Life Sciences Ltd (WVE)
Wave Life Sciences Ltd (NASDAQ: WVE) saw its 5-day average volume 2.15 million, a positive change from its year-to-date volume of 1.12 million. As of the previous 9 days, the stock’s Stochastic %D was 3.51%. Additionally, its Average True Range was 0.77.
During the past 100 days, Wave Life Sciences Ltd’s (WVE) raw stochastic average was set at 3.10%, which indicates a significant decrease from 6.41% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 81.92% in the past 14 days, which was higher than the 72.01% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $10.20, while its 200-day Moving Average is $9.81. Nevertheless, the first resistance level for the watch stands at $6.20 in the near term. At $6.61, the stock is likely to face the second major resistance level. The third major resistance level sits at $6.98. If the price goes on to break the first support level at $5.42, it is likely to go to the next support level at $5.05. The third support level lies at $4.64 if the price breaches the second support level.
Wave Life Sciences Ltd (NASDAQ: WVE) Key Stats
The company with the Market Capitalisation of 890.22 million has total of 153,486K Shares Outstanding. Its annual sales at the moment are 108,300 K in contrast with the sum of -97,010 K annual income. Company’s last quarter sales were recorded 83,750 K and last quarter income was 29,250 K.
